Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.20p
   
  • Change Today:
      0.050p
  • 52 Week High: 11.85
  • 52 Week Low: 3.82
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 1,526,850
  • Market Cap: £22.40m

Eden Research signs exclusive agreement with Sumi Agro France

Date: Monday 01 Dec 2014

LONDON (ShareCast) - Intellectual property developer Eden Research confirmed it has signed an exclusive licence agreement with Sumi Agro France.
Under the deal, Sumi will assume control of 3AEY, an Eden-developed plant protection product in France, and will be entitled to trial, register, develop and sell other plant protection products to be used in the country.

"Ensuring that we have the right partner which is able to fully exploit the opportunities for effective products such as 3AEY in this market is critical," said group chief executive Sean Smith.

"We strongly believe that Sumi Agro France is that partner and expect that Eden will benefit greatly from the weight that their name and expertise carries in France."

The licence lasts for 20 years and covers the use of 3AEY in a number of agricultural applications and the technology will be used to fight Botrytis, a fungus that affects many plants and is a major concern across Europe.

"This agreement expresses our Sumi Agro commitment to invest in modern crop protection solutions based on conventional as well as BioControl tools," said Antoine Meye, president of Sumi Agro.

Eden Research shares were up 3.56% to 11.65p at 09:05 on Monday.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Eden Research Market Data

Currency UK Pounds
Share Price 4.20p
Change Today 0.050p
% Change 1.20 %
52 Week High 11.85
52 Week Low 3.82
Volume 1,526,850
Shares Issued 533.35m
Market Cap £22.40m

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.37% below the market average17.37% below the market average17.37% below the market average17.37% below the market average17.37% below the market average
29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average
Price Trend
21.6% below the market average21.6% below the market average21.6% below the market average21.6% below the market average21.6% below the market average
16.98% above the sector average16.98% above the sector average16.98% above the sector average16.98% above the sector average16.98% above the sector average
Income Not Available
Growth
49.00% above the market average49.00% above the market average49.00% above the market average49.00% above the market average49.00% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average

Eden Research Dividends

No dividends found

Trades for 14-Jun-2024

Time Volume / Share Price
15:59 596,915 @ 4.40p
15:05 459,563 @ 4.35p
14:52 7,933 @ 4.08p
14:46 12,737 @ 4.08p
14:37 13,833 @ 3.82p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page